Skip to main content
Top
Published in: Gastric Cancer 3/2016

01-07-2016 | Original Article

Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101

Authors: Yuichi Ito, Takaki Yoshikawa, Michitaka Fujiwara, Hiroshi Kojima, Takanori Matsui, Yoshinari Mochizuki, Haruhiko Cho, Toru Aoyama, Seiji Ito, Kazunari Misawa, Hiroshi Nakayama, Yuki Morioka, Akiharu Ishiyama, Chie Tanaka, Satoshi Morita, Junichi Sakamoto, Yasuhiro Kodera

Published in: Gastric Cancer | Issue 3/2016

Login to get access

Abstract

Background

Total gastrectomy has detrimental effects on postoperative nutritional status and quality of life (QOL), but it is often unavoidable in the treatment of gastric cancer. Roux-en-Y (RY) is the most common reconstruction method following total gastrectomy. Trials to explore other means of reconstruction have been conducted but have failed to identify a method that is globally accepted.

Methods

Aboral pouch reconstruction (AP), in which an anisoperistaltic jejunal pouch is created in the Y limb of the RY reconstruction, is considered effective and technically feasible. A prospective randomized trial was conducted to compare AP with RY. Gastric cancer patients requiring total gastrectomy for R0 resection were randomly assigned during surgery to receive either RY (n = 51) or AP (n = 49). Postoperative QOL as assessed by the EORTC QLQ-C30 and STO22, body composition, and morbidity were compared between the two reconstruction methods. The physical functioning score of the QLQ-C30 was selected as the primary endpoint.

Results

The incidences of postoperative complications were similar between the two groups (29 % in the RY group and 27 % in the AP group). No significant difference was observed in the physical functioning score, and the superiority of AP was demonstrated only for the nausea and vomiting score at 12 months (p = 0.041) and the reflux score at 1 month (p = 0.036). No significant differences were observed in body composition or serum biochemistry.

Conclusions

Although AP was safely implemented, no increased benefits in nutritional or QOL-related parameters were observed for this method over RY within 12 months postoperatively.
Literature
1.
go back to reference Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247:759–65.CrossRefPubMed Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247:759–65.CrossRefPubMed
2.
go back to reference Troidl H, Kusche J, Vestweber KH, Eypasch E, Maul U. Pouch versus esophagojejunostomy after total gastrectomy: a randomized clinical trial. World J Surg. 1987;11:699–712.CrossRefPubMed Troidl H, Kusche J, Vestweber KH, Eypasch E, Maul U. Pouch versus esophagojejunostomy after total gastrectomy: a randomized clinical trial. World J Surg. 1987;11:699–712.CrossRefPubMed
3.
go back to reference Nakane Y, Okumura S, Akehira K, Okamura S, Boku T, Okusa T, et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg. 1995;222:27–35. Nakane Y, Okumura S, Akehira K, Okamura S, Boku T, Okusa T, et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg. 1995;222:27–35.
4.
go back to reference Bozzetti F, Bonfanti G, Castellani R, Maffioli L, Rubino A, Diazzi G, et al. Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg. 1996;183:243–8.PubMed Bozzetti F, Bonfanti G, Castellani R, Maffioli L, Rubino A, Diazzi G, et al. Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg. 1996;183:243–8.PubMed
5.
go back to reference Schwarz A, Buchler M, Usinger K, Rieger H, Glasbrenner B, Friess H, et al. Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg. 1996;20:60–6.CrossRefPubMed Schwarz A, Buchler M, Usinger K, Rieger H, Glasbrenner B, Friess H, et al. Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg. 1996;20:60–6.CrossRefPubMed
6.
go back to reference Liedman B, Andersson H, Bosaeus I, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997;21:416–20.CrossRefPubMed Liedman B, Andersson H, Bosaeus I, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997;21:416–20.CrossRefPubMed
7.
go back to reference Iivonen MK, Koskinen MO, Ikonen TJ, Matikainen MJ. Emptying of the jejunal pouch and Roux-en-Y limb after total gastrectomy—a randomised, prospective study. Eur J Surg. 1999;165:742–7.CrossRefPubMed Iivonen MK, Koskinen MO, Ikonen TJ, Matikainen MJ. Emptying of the jejunal pouch and Roux-en-Y limb after total gastrectomy—a randomised, prospective study. Eur J Surg. 1999;165:742–7.CrossRefPubMed
8.
go back to reference Adachi S, Inagawa S, Enomoto T, Shinozaki E, Oda T, Kawamoto T. Subjective and functional results after total gastrectomy: prospective study for longterm comparison of reconstruction procedures. Gastric Cancer. 2003;6:24–9.CrossRefPubMed Adachi S, Inagawa S, Enomoto T, Shinozaki E, Oda T, Kawamoto T. Subjective and functional results after total gastrectomy: prospective study for longterm comparison of reconstruction procedures. Gastric Cancer. 2003;6:24–9.CrossRefPubMed
9.
go back to reference Kono K, Iizuka H, Sekikawa T, Sugai H, Takahashi A, Fujii H, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg. 2003;185:150–4.CrossRefPubMed Kono K, Iizuka H, Sekikawa T, Sugai H, Takahashi A, Fujii H, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg. 2003;185:150–4.CrossRefPubMed
10.
go back to reference Horvath OP, Kalmar K, Cseke L, Poto L, Zambo K. Nutritional and life-quality consequences of aboral pouch construction after total gastrectomy: a randomized, controlled study. Eur J Surg Oncol. 2001;27:558–63.CrossRefPubMed Horvath OP, Kalmar K, Cseke L, Poto L, Zambo K. Nutritional and life-quality consequences of aboral pouch construction after total gastrectomy: a randomized, controlled study. Eur J Surg Oncol. 2001;27:558–63.CrossRefPubMed
11.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
12.
go back to reference Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
13.
go back to reference Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37:966–71.CrossRefPubMed Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37:966–71.CrossRefPubMed
14.
go back to reference Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40:2260–8.CrossRefPubMed Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40:2260–8.CrossRefPubMed
15.
go back to reference Fayers PM, Aaronson NK, Bjordal K et al. EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001. Fayers PM, Aaronson NK, Bjordal K et al. EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001.
16.
go back to reference Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer. 1998;34:810–5. Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer. 1998;34:810–5.
17.
go back to reference Morita S, Kaptein AA, Oba K, Sakamoto J. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psychooncology. 2008;17:474–9.CrossRefPubMed Morita S, Kaptein AA, Oba K, Sakamoto J. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psychooncology. 2008;17:474–9.CrossRefPubMed
18.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefPubMed Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.CrossRefPubMed
19.
go back to reference Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, et al. Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol. 2015;22:2560–6. Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, et al. Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol. 2015;22:2560–6.
20.
go back to reference Gertler R, Rosenberg R, Feith M, Schuster T, Friess H. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol. 2009;104:2838–51.CrossRefPubMed Gertler R, Rosenberg R, Feith M, Schuster T, Friess H. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol. 2009;104:2838–51.CrossRefPubMed
21.
go back to reference Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg. 2011;35:357–64.CrossRefPubMed Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg. 2011;35:357–64.CrossRefPubMed
22.
go back to reference Ikeda M, Ueda T, Shiba T. Reconstruction after total gastrectomy by the interposition of a doble jejunal pouch using a double stapling technique. Br J Surg. 1998;85:398–402.CrossRefPubMed Ikeda M, Ueda T, Shiba T. Reconstruction after total gastrectomy by the interposition of a doble jejunal pouch using a double stapling technique. Br J Surg. 1998;85:398–402.CrossRefPubMed
23.
go back to reference Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18:147–58.CrossRefPubMed Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18:147–58.CrossRefPubMed
24.
go back to reference Nakamura M, Hosoya Y, Yano M, Doki Y, Miyashiro I, Kurashina K, et al. Extent of gastric resection impacts patient quality of life: the dysfunction after upper gastrointestinal surgery for cancer (DAUGS32) scoring system. Ann Surg Oncol. 2011;18:314–20.CrossRefPubMed Nakamura M, Hosoya Y, Yano M, Doki Y, Miyashiro I, Kurashina K, et al. Extent of gastric resection impacts patient quality of life: the dysfunction after upper gastrointestinal surgery for cancer (DAUGS32) scoring system. Ann Surg Oncol. 2011;18:314–20.CrossRefPubMed
25.
go back to reference Namikawa T, Hiki N, Kinami S, Okabe H, Urushihara T, Kawahira H, et al. Factors that minimize postogastrectomy symptoms following pylorus-preserving gastrectomy: assessment using a newly developed scale (PGSAS-45). Gastric Cancer. 2015;18:397–406.CrossRefPubMed Namikawa T, Hiki N, Kinami S, Okabe H, Urushihara T, Kawahira H, et al. Factors that minimize postogastrectomy symptoms following pylorus-preserving gastrectomy: assessment using a newly developed scale (PGSAS-45). Gastric Cancer. 2015;18:397–406.CrossRefPubMed
26.
go back to reference Terashima M, Tanabe K, Yoshida M, Kawahira H, Inada T, Okabe H, et al. Postgastrectomy syndrome assessment scale (PGSAS)-45 and changes in body weight are useful tools for evaluation of reconstruction methods following distal gastrectomy. Ann Surg Oncol. 2014;21(Suppl 3):370–8.CrossRef Terashima M, Tanabe K, Yoshida M, Kawahira H, Inada T, Okabe H, et al. Postgastrectomy syndrome assessment scale (PGSAS)-45 and changes in body weight are useful tools for evaluation of reconstruction methods following distal gastrectomy. Ann Surg Oncol. 2014;21(Suppl 3):370–8.CrossRef
27.
go back to reference Takiguchi N, Takahashi M, Ikeda M, Inagawa S, Ueda S, Nobuoka T, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer. 2015;18:407–16.CrossRefPubMed Takiguchi N, Takahashi M, Ikeda M, Inagawa S, Ueda S, Nobuoka T, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer. 2015;18:407–16.CrossRefPubMed
Metadata
Title
Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101
Authors
Yuichi Ito
Takaki Yoshikawa
Michitaka Fujiwara
Hiroshi Kojima
Takanori Matsui
Yoshinari Mochizuki
Haruhiko Cho
Toru Aoyama
Seiji Ito
Kazunari Misawa
Hiroshi Nakayama
Yuki Morioka
Akiharu Ishiyama
Chie Tanaka
Satoshi Morita
Junichi Sakamoto
Yasuhiro Kodera
Publication date
01-07-2016
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 3/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0529-5

Other articles of this Issue 3/2016

Gastric Cancer 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.